Qiagen NV (QGEN)
41.89
+0.67
(+1.63%)
USD |
NYSE |
Apr 23, 16:00
41.88
0.00 (0.00%)
Pre-Market: 20:00
Qiagen Profit Margin (Quarterly): 19.18% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.18% |
| September 30, 2023 | 16.35% |
| June 30, 2023 | 16.33% |
| March 31, 2023 | |
| December 31, 2022 | 17.84% |
| September 30, 2022 | 16.49% |
| June 30, 2022 | 18.75% |
| March 31, 2022 | 24.72% |
| December 31, 2021 | 22.18% |
| September 30, 2021 | 24.90% |
| June 30, 2021 | 21.34% |
| March 31, 2021 | 22.78% |
| December 31, 2020 | 37.23% |
| September 30, 2020 | 3.50% |
| June 30, 2020 | 20.25% |
| March 31, 2020 | 10.70% |
| December 31, 2019 | 10.87% |
| September 30, 2019 | -41.98% |
| June 30, 2019 | 11.72% |
| March 31, 2019 | 8.47% |
| December 31, 2018 | 15.12% |
| September 30, 2018 | 15.96% |
| June 30, 2018 | 9.76% |
| March 31, 2018 | 9.40% |
| December 31, 2017 | -10.00% |
| Date | Value |
|---|---|
| September 30, 2017 | 13.32% |
| June 30, 2017 | 4.00% |
| March 31, 2017 | 5.74% |
| December 31, 2016 | 2.35% |
| September 30, 2016 | 10.28% |
| June 30, 2016 | 6.36% |
| March 31, 2016 | 5.27% |
| December 31, 2015 | 14.81% |
| September 30, 2015 | 10.79% |
| June 30, 2015 | 7.86% |
| March 31, 2015 | 6.53% |
| December 31, 2014 | 7.10% |
| September 30, 2014 | 10.31% |
| June 30, 2014 | 9.92% |
| March 31, 2014 | 7.34% |
| December 31, 2013 | 16.66% |
| September 30, 2013 | 12.64% |
| June 30, 2013 | -16.42% |
| March 31, 2013 | 6.58% |
| December 31, 2012 | 11.09% |
| September 30, 2012 | 9.58% |
| June 30, 2012 | 10.85% |
| March 31, 2012 | 9.65% |
| December 31, 2011 | -0.11% |
| September 30, 2011 | 12.17% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-41.98%
Minimum
Sep 2019
37.23%
Maximum
Dec 2020
15.18%
Average
18.30%
Median
Profit Margin (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | -- |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 14.97% |
| uniQure NV | -1.09K% |
| ProQR Therapeutics NV | -167.0% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 62.08% |
| Operating Margin (Quarterly) | 23.86% |